Dry Eye Disease

Look what my Secret Santa brought me!

Alcon has completed the acquisition of Aerie Pharmaceuticals, according to a press release.

Okyo Pharma has submitted an investigational new drug application to the FDA for OK-101 for the treatment of dry eye disease.

Last month, I set out to discover what is in the cosmetics used around the eye that contributes to worsening dry eye disease.

There have been several studies on the use of femtosecond astigmatic incisions for the correction of astigmatism at the time of cataract surgery.

The success of ocular surgery, especially refractive surgery, hinges on the health of the ocular surface.

The phase 2b/3 OASIS-1 trial of ALY688 ophthalmic solution for the treatment of dry eye disease has completed patient enrollment, according to a press release from Allysta Pharmaceuticals.

Viatris Inc. announced that it will be acquiring both Oyster Point Pharma and Famy Life Sciences, which will help the company meet its goal of creating an ophthalmology franchise, according to a press release.

I would like to congratulate Mitch Jackson on his 100th Premium Channel column in OSN. Mitch’s entertaining approach to presenting cutting-edge techniques and technology in premium refractive surgery has always matched his ebullient personality.

Anything that happens to the eyelid will directly affect the eye’s surface. As a result, I cannot treat dry eye disease or any pathology on the surface without addressing the eyelids.